#Japan #ALS #Kawasaki #Hospice #Human Life Care

A New Supportive Hospice for Terminally Ill Patients

In March 2026, Human Life Care Inc., based in Shinjuku, Tokyo, is set to launch the "Human Life Care Noborito Hospice Home" located in Tama Ward, Kawasaki City, Kanagawa Prefecture. This new residential hospice will primarily cater to those suffering from neurodegenerative diseases and terminal cancer, marking the third hospice facility operated by the company.

Key Highlights of the New Facility

The Human Life Care Noborito Hospice Home aims to provide comprehensive care and support for terminally ill patients, particularly those diagnosed with diseases such as ALS (Amyotrophic Lateral Sclerosis) and Parkinson's disease. The facility will collaborate closely with nearby medical institutions, ensuring a cohesive approach to nursing and medical care, available 24/7.

Located strategically within the Kawasaki area, the hospice will connect with existing facilities in Kawasaki, Yokohama, and Machida, allowing seamless support across various care settings.

What Sets Human Life Care Noborito Hospice Home Apart

The Noborito Hospice will not only offer a home-like environment but also focus on maintaining the quality of life (QOL) of its residents. With the foundation laid by Human Life Care’s extensive experience since the introduction of long-term care insurance in 1999, the hospice will benefit from highly trained staff who are equipped with unique caregiving expertise.

Residents will receive a blend of services, including personalized care and nursing alongside medical treatment, such as home visits by nurses and emergency medical support. The hospice will also implement specialized dental care through partnerships with dental professionals to ensure comprehensive oral health management and swallowing training.

Innovative and Quality Care

Introducing new services to meet the needs of patients, this hospice aims at providing high-quality care for those who may not find placement in conventional nursing homes due to their complex medical needs.

The facility will serve up to 30 residents, with all rooms being private to ensure comfort and dignity. Those eligible for residency must be diagnosed with specified medical conditions or terminal cancer, and the hospice will be authorized to manage various medical procedures, from insulin administration to tracheostomy care.

Human Life Care aims to expand such facilities across the Tokyo metropolitan area, continuing to build environments where residents can feel at ease within their familiar surroundings. The organization is dedicated to enhancing the training and education of its staff to maintain compliance and provide adequate care.

Creating a Safe Environment for All

By establishing the Human Life Care Noborito Hospice Home, the company strives to create spaces that allow individuals to continue living in their communities with reassurance and comfort. This vision aligns with global sustainability goals, particularly in achieving health and welfare for everyone, as emphasized by the SDGs (Sustainable Development Goals).

For further inquiries regarding the new hospice opening or to learn more about Human Life Care's extensive network of services, interested parties can contact the preparation office at 0120-47-0294, or visit their official website.

Facility Overview

• - Location: 211 Noborito, Tama Ward, Kawasaki City, Kanagawa Prefecture
• - Capacity: 30 residents (all rooms private)
• - Accessible Medical Procedures: Includes end-of-life care tasks such as respiratory support and pain management.

By advancing hospice services, Human Life Care is contributing to the creation of environments where people can live safely and comfortably in their cherished communities.